Glutaminolysis is required for transforming growth factor-β1–induced myofibroblast differentiation and activation
出版年份 2017 全文链接
标题
Glutaminolysis is required for transforming growth factor-β1–induced myofibroblast differentiation and activation
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 4, Pages 1218-1228
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2017-12-09
DOI
10.1074/jbc.ra117.000444
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts
- (2017) Jindong Shi et al. Scientific Reports
- The emerging role and targetability of the TCA cycle in cancer metabolism
- (2017) Nicole M. Anderson et al. Protein & Cell
- HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival
- (2016) Steve Stegen et al. Cell Metabolism
- Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity
- (2016) Rob J.W. Arts et al. Cell Metabolism
- Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions
- (2016) Stephen P. Burr et al. Cell Metabolism
- Normoxic accumulation of HIF1α is associated with glutaminolysis
- (2016) Matthias Kappler et al. Clinical Oral Investigations
- Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels
- (2016) M. Ryan Smith et al. Redox Biology
- Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
- (2015) Na Xie et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Enhanced OXPHOS, glutaminolysis and -oxidation constitute the metastatic phenotype of melanoma cells
- (2015) M. F. Rodrigues et al. BIOCHEMICAL JOURNAL
- Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation
- (2015) Karen Bernard et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
- (2015) Decai Yu et al. Oncotarget
- Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells
- (2015) Yue-Zhi Lee et al. Oncotarget
- Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
- (2013) Yong Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia
- (2013) J. Fan et al. Molecular Systems Biology
- Host Responses in Tissue Repair and Fibrosis
- (2012) Jeremy S. Duffield et al. Annual Review of Pathology-Mechanisms of Disease
- Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
- (2012) Anne Le et al. Cell Metabolism
- Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β
- (2011) Nathan Sandbo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Assessing bioenergetic function in response to oxidative stress by metabolic profiling
- (2011) Brian P. Dranka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion
- (2007) Elisabeth L. Pagé et al. MOLECULAR BIOLOGY OF THE CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started